Katleen De Preter

16PUBLICATIONS
125CO-AUTHORS
Predictive and prognostic markersMolecular targetsGenome structure and regulationOther creative arts and writing not elsewhere classifiedGenomics and transcriptomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Oct 30, 2024
Defining the optimal setting for transcriptomic analyses on blood samples for response prediction in immunotherapy-treated NSCLC patients.

Álvaro Marcos Rubio, Seoyeon Oh, Sofie Roelandt

|Dec 04, 2023
MYCN and SNRPD3 cooperate to maintain a balance of alternative splicing events that drives neuroblastoma progression.

Alice Salib, Nisitha Jayatilleke, Janith A Seneviratne

|Nov 14, 2023
Mitotic Dysregulation at Tumor Initiation Creates a Therapeutic Vulnerability to Combination Anti-Mitotic and Pro-Apoptotic Agents for MYCN-Driven Neuroblastoma.

Lei Zhai, Anushree Balachandran, Rebecca Larkin

|Mar 07, 2023
SOX11 regulates SWI/SNF complex components as member of the adrenergic neuroblastoma core regulatory circuitry.

Bieke Decaesteker, Amber Louwagie, Siebe Loontiens

|Mar 03, 2023
Memory of stochastic single-cell apoptotic signaling promotes chemoresistance in neuroblastoma.

Jordan F Hastings, Sharissa L Latham, Alvin Kamili

|Jul 20, 2022
RRM2 enhances MYCN-driven neuroblastoma formation and acts as a synergistic target with CHK1 inhibition.

Carolina Nunes, Lisa Depestel, Liselot Mus

Pageof 3

Frequent Collaborators

6 joint publications

Pieter Mestdagh

5 joint publications

Frank Speleman

5 joint publications

Jo Vandesompele

4 joint publications

Francisco Avila Cobos